This 2006 study by Wang et al. investigates the dual role of N-acetylcysteine (NAC) in acute ethanol-induced liver injury using a murine model. Female ICR mice received a single oral dose of ethanol (6 g/kg), with NAC administered either 30 minutes before (pretreatment) or 4 hours after (post-treatment) ethanol exposure.
This 2010 preclinical study by Ilic et al., published in the Journal of Physiology and Pharmacology, investigated the protective effects of the stable gastric pentadecapeptide BPC 157 against severe paracetamol-induced toxicity in rats. Administering a high hepatotoxic dose of paracetamol (5 g/kg intraperitoneally) led to rapid onset of generalized convulsions,
This study evaluated copper and zinc concentrations in serum, urine, and hair of patients with Wilson’s disease undergoing treatment with penicillamine and zinc. The findings indicated that serum copper levels were significantly reduced, while urinary copper excretion was elevated, reflecting effective chelation therapy. Serum zinc levels were increased due to
This 2018 review article, published in Diseases, examines the efficacy of vitamin E supplementation in treating nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH). The authors conducted a systematic review of studies up to June 2018, focusing on the impact of vitamin E, particularly alpha-tocopherol,
This 1975 study, published in the Journal of Clinical Investigation, investigates how chronic alcohol consumption affects vitamin B6 metabolism, specifically focusing on pyridoxal 5′-phosphate (PLP), the active coenzyme form of vitamin B6. The researchers found that chronic ethanol intake significantly reduces hepatic PLP levels in rats, regardless of their vitamin
This 2021 systematic review and meta-analysis, published in Journal of Gastroenterology and Hepatology, evaluated the efficacy of vitamin E supplementation in adults with non-alcoholic fatty liver disease (NAFLD). The analysis included eight randomized controlled trials encompassing 669 participants. Results demonstrated that vitamin E supplementation significantly reduced serum alanine aminotransferase (ALT)
